| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |